Clinical Trial Update: A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog® [Phase 4]

View source ↗

Summary

A Phase IV trial comparing Exubera (insulin human inhalation powder) with Humalog (insulin lispro) in type 1 diabetes was terminated, with results posted in 200…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Exubera (insulin inhalation powder)
• Humalog (insulin lispro)

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 1 | Phase 4 | Status: TERMINATED | Results posted: 2009-08-11